| [1] |
SchollI, ZillJM, HärterM，et al. An integrative model of patient-centeredness: a systematic review and concept analysis[J]. PLoS One, 2014, 9(9): e107828.
|
| [2] |
CollinsFS, VarmusH. A new initiative on precision medicine[J]. N Engl J Med, 2015, 372(9): 793-795.
|
| [3] |
CanonicaGW, BachertC, HellingsP, et al. Allergen immunotherapy (AIT): a prototype of precision medicine[J]. World Allergy Organ J, 2015, 8(1): 31.
|
| [4] |
HobinJA, DeschampsAM, BockmanR, et al. Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles[J]. J Transl Med, 2012, 10(1): 72.
|
| [5] |
SingCW, CheungCL, WongIC. Pharmacogenomics: how close/far are we to practising individualized medicine for children？[J]. Br J Clin Pharmacol, 2015, 79(3): 419-428.
|
| [6] |
McGrathS, GhersiD. Building towards precision medicine: empowering medical professionals for the next revolution[J]. BMC Med Genomics, 2016, 9(1): 23.
|
| [7] |
杨锡强. 疾病基因型-表型知识应进入儿科医师的视野[J]. 中华儿科杂志，2013, 51(9): 641-644.
|
| [8] |
ChenR, SnyderM. Promise of personalized omics to precision medicine[J]. Wiley Interdiscip Rev SystBiol Med, 2013, 5(1): 73-82.
|
| [9] |
HoodL, FloresM. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory[J]. N Biotechnol, 2012, 29(6): 613-624.
|
| [10] |
中国制药网. 2016年国家重点研发专项指南发布"精准医学研究"入选[EB/OL]. (2016-03-10)[2016-06-10]．
URL
|
| [11] |
赵晓东，杨锡强. 我国儿童免疫学的发展轨迹[J]. 中华儿科杂志，2015, 53(2): 84-86.
|
| [12] |
PicardC, Al-HerzW, BousfihaA, et al. Primary immunodeficiency diseases: an update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015[J]. J ClinImmunol, 2015, 35(8): 696-726.
|
| [13] |
BrutonOC. Agammaglobulinemia[J]. Pediatrics, 1952, 9(6): 722-728.
|
| [14] |
GoodRA. Clinical investigations in patients with agammaglobulinemia[J]. J Lab Clin Med, 1954, 44(5): 803-807.
|
| [15] |
FarrarJE, RohrerJ, ConleyME. Neutropenia in X-linked agammaglobulinemia[J]. Clin Immunol Immunopathol，1996, 81(3): 271-276.
|
| [16] |
SaffranDC, ParoliniO, FitchHM, et al. Brief report: a point mutation in the SH2 domain of Bruton′s tyrosine kinase in atypical X-linked agammaglobulinemia[J]. N Engl J Med, 1994, 330(21): 1488-1491.
|
| [17] |
VetrieD, VořechovskýI, SiderasP, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases[J]. J Immunol, 2012, 188(7): 2948-2955.
|
| [18] |
ConleyME, FarmerDM, DobbsAK, et al. A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease[J]. Clin Exp Immunol, 2008, 152(1): 39-44.
|
| [19] |
MarronTU, Martinez-GalloM, YuJE, et al. Toll-like receptor 4-，7-，and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines[J]. J Allergy Clin Immunol, 2012, 129(1): 184-190. e1-e4.
|
| [20] |
Hernandez-TrujilloVP, ScalchunesC, Cunningham-RundlesC, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia[J]. J Clin Immunol, 2014, 34(6): 627-632.
|
| [21] |
RameshM, SimchoniN, HammD, et al. High-throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia[J]. Clin Immunol, 2015, 161(2): 190-196.
|
| [22] |
GasparHB, ConleyME. Immunodeficiency review: early B cell defects[J]. Clin Exp Immunol, 2000, 119(3): 383-389.
|
| [23] |
EspanolT, PrevotJ, DrabwellJ, et al. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment[J]. Patient Prefer Adherence, 2014, 8: 621-629.
|
| [24] |
KernsHM, RyuBY, StirlingBV, et al. B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia[J]. Blood, 2010, 115(11): 2146-2155.
|
| [25] |
BestasB, TurunenJJ, BlombergKE, et al. Splice-correction strategies for treatment of X-linked agammaglobulinemia[J]. Curr Allergy Asthma Rep, 2015, 15(3): 510.
|
| [26] |
郑缓，吴彤，陆道培，等. 异基因骨髓移植治疗X连锁无丙种球蛋白血症一例[J]. 中华儿科杂志，1991, 29(6): 324-326.
|
| [27] |
黄晓军，石红霞，郭乃榄，等. 异基因骨髓移植治疗Bruton病[J]. 中华血液学杂志，2002, 23(10): 528-530.
|
| [28] |
IkegameK, ImaiK, YamashitaM, et al. Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity[J]. J Hematol Oncol, 2016, 9：9.
|
| [29] |
NavabiB, UptonJE. Primary immune deficiencies associated with eosinophilia[J]. Allergy Asthma Clin Immunol, 2016, 12: 27.
|
| [30] |
CasanovaJL. Severe infectious diseases of childhood as monogenic inborn errors of immunity[J]．Proc Natl Acad Sci USA, 2015, 112(51): E7128-E7137.
|
| [31] |
Costa-CarvalhoBT, GrumachAS, FrancoJL, et al. Attending to warning signs ofprimary immune deficiency diseases across the range of clinical practice[J]. J Clin Immunol, 2014, 34(1): 10-22.
|